Dr. Anthony F. Yu, MD

Dr. Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Yu's NPI, 1043418833, was assigned on July 3, 2007. Dr. Yu graduated from Harvard Medical School in 2007. Dr. Yu's New York license number on file is 256204.

Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Yu is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Memorial Cardiopulmonary Group. Dmand AI also links Dr. Yu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yu is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Yu's licenses on file in 5 states: New York, Florida, New Jersey, Connecticut and Pennsylvania.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart failure, high cholesterol and ventricular tachycardia among the conditions Dr. Yu treats.

CMS data shows 2,415 Medicare services from Dr. Yu across 9 procedure codes in 2024, for 1,828 Medicare patients. Medicare paid $49,187 for them.

CMS counts 1,828 Medicare patients who saw Dr. Yu in 2024. The largest group is 65 to 74, with 830 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 69, with 51% women.

In 2024, Dr. Yu wrote 831 Medicare Part D claims for 125 patients. 81% of them were for generic drugs. CMS names the drug for 690 of them, across 19 drugs with 11 or more claims each, at $162,093 in total drug cost. In 2023, CMS named 506 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Yu for performance year 2024, reported as part of a group. Dr. Yu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yu as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Dr. Yu, published from 2013 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Cardiotoxicity and Receptor, ErbB-2. Dr. Yu has published most often in Breast Cancer Res Treat. Dr. Yu's most frequent co-authors are Chau T. Dang, MD, Jennifer E. Liu, MD and Clifford A. Hudis, MD.

Dmand AI links Dr. Yu to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 27 general payments to Dr. Yu from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Bristol-Myers Squibb Company paid the most, $6,491. It also lists 1 research payment totaling $3,000 in 2020.

Dr. Yu graduated from Harvard Medical School in 2007. Dr. Yu is a member of ACC.

Dr. Yu is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.